4//SEC Filing
Harper Molly 4
Accession 0001161697-24-000502
CIK 0001369568other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:00 PM ET
Size
7.5 KB
Accession
0001161697-24-000502
Insider Transaction Report
Form 4
Harper Molly
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-09−1,413→ 132,607 total→ Common Stock (1,413 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2024-12-09+1,413→ 1,413 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 9, 2024.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001871470
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:00 PM ET
- Size
- 7.5 KB